EP2377514A3 - Formulation parentérale liquide comportant un matériau de tramadol et paracétamol - Google Patents

Formulation parentérale liquide comportant un matériau de tramadol et paracétamol Download PDF

Info

Publication number
EP2377514A3
EP2377514A3 EP11003295A EP11003295A EP2377514A3 EP 2377514 A3 EP2377514 A3 EP 2377514A3 EP 11003295 A EP11003295 A EP 11003295A EP 11003295 A EP11003295 A EP 11003295A EP 2377514 A3 EP2377514 A3 EP 2377514A3
Authority
EP
European Patent Office
Prior art keywords
paracetamol
formulation
tramadol material
parenteral formulation
tramadol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11003295A
Other languages
German (de)
English (en)
Other versions
EP2377514A2 (fr
Inventor
Tseti Ioulia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Uni Pharma Kleon Tsetis Pharmaceutical Laboratories SA
Original Assignee
Uni Pharma Kleon Tsetis Pharmaceutical Laboratories SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Pharma Kleon Tsetis Pharmaceutical Laboratories SA filed Critical Uni Pharma Kleon Tsetis Pharmaceutical Laboratories SA
Publication of EP2377514A2 publication Critical patent/EP2377514A2/fr
Publication of EP2377514A3 publication Critical patent/EP2377514A3/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP11003295A 2010-04-19 2011-04-19 Formulation parentérale liquide comportant un matériau de tramadol et paracétamol Withdrawn EP2377514A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR2010100233 2010-04-19

Publications (2)

Publication Number Publication Date
EP2377514A2 EP2377514A2 (fr) 2011-10-19
EP2377514A3 true EP2377514A3 (fr) 2012-04-11

Family

ID=44514336

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11003295A Withdrawn EP2377514A3 (fr) 2010-04-19 2011-04-19 Formulation parentérale liquide comportant un matériau de tramadol et paracétamol

Country Status (1)

Country Link
EP (1) EP2377514A3 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA201300398B (en) 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
TWI620577B (zh) * 2016-11-23 2018-04-11 乙醯胺酚及曲馬多共溶複方止痛口服液
CN110115708A (zh) * 2018-02-07 2019-08-13 保瑞药业股份有限公司 乙酰胺酚及曲马多共溶复方止痛口服液
GR1009630B (el) * 2018-03-14 2019-10-25 Laboserve Φαρμακευτικη Βιομηχανια Α.Ε. Ποσιμα διαλυματα που περιλαμβανουν τραμαδολη και ακεταμινοφαινη

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993004675A1 (fr) * 1991-09-06 1993-03-18 Mcneilab, Inc. Composition renfermant une matiere a base de tramadol et de l'acetaminophene, et son utilisation
WO2003051398A1 (fr) * 2001-12-18 2003-06-26 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Composition parenterale de paracetamol
CN101147731A (zh) * 2006-11-22 2008-03-26 陈旭良 盐酸曲马多与对乙酰氨基酚组合的注射剂

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993004675A1 (fr) * 1991-09-06 1993-03-18 Mcneilab, Inc. Composition renfermant une matiere a base de tramadol et de l'acetaminophene, et son utilisation
WO2003051398A1 (fr) * 2001-12-18 2003-06-26 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Composition parenterale de paracetamol
CN101147731A (zh) * 2006-11-22 2008-03-26 陈旭良 盐酸曲马多与对乙酰氨基酚组合的注射剂

Also Published As

Publication number Publication date
EP2377514A2 (fr) 2011-10-19

Similar Documents

Publication Publication Date Title
EP2376010A4 (fr) Systèmes et procédés avec capacité d'interruption/reprise pour traitement de cellules sous-cutanées riches en lipides
EP2377514A3 (fr) Formulation parentérale liquide comportant un matériau de tramadol et paracétamol
IL250549A0 (en) Acetyl analogs of insulin that are resistant to protease and their use for the preparation of a drug for the treatment and prevention of diabetes
IL225183A0 (en) A programmable remote that includes a flexible user interface and common device adjustments
HK1207595A1 (en) Chemical engines and methods for their use, especially in the injection of highly viscous fluids
PT2638863E (pt) Material de sutura cirúrgica com farpas cortadas no estado não estirado
WO2009112930A3 (fr) Dispositif de fermeture médical
EP2149020A4 (fr) Structure de modification de la hauteur d'étagères et réfrigérateur la comprenant
EP2537064A4 (fr) Unité de rétroéclairage et afficheur à cristaux liquides comprenant cette unité
GB201313769D0 (en) Antenna device
EP2286087A4 (fr) Pompe cryogénique employant des alliages étain-antimoine et procédés d utilisation
SG10201500868WA (en) Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2542491A4 (fr) Dispositif pour la distribution et la présentation de produits et ensembles emballages à utiliser avec celui-ci
IL221746A (en) Amisulfide for use in the treatment of nausea and vomiting
EP2650635A4 (fr) Dispositif de distribution de réfrigérant et échangeur de chaleur équipé d'un tel dispositif
WO2012092343A3 (fr) Hydrogel perforé
AU334869S (en) Implantable blood pump
PL390170A1 (pl) Urządzenie do regulacji przepływu dwufazowego i przenośny rozpylacz cieczy z przepływem dwufazowym
EP4249535A4 (fr) Polyester à cristaux liquides, composition de polyester à cristaux liquides, et utilisation associée
HK1176796A2 (en) Diamond of 81 facets with internal featuring ten hearts and ten arrows
PL2576425T3 (pl) Układ pompy i jednostka zasilająca na paliwo z układem pompy
WO2015169453A3 (fr) Dispositif pour fixer une broche de kirschner
EP3449917A3 (fr) Tapentadol pour empecher la chronicisation de la douleur
EP2709021A3 (fr) Dispositif de contrôle d'affichage de graphiques, procédé de contrôle d'affichage de graphiques et support de stockage permettant de stocker le programme de contrôle d'affichage de graphiques
ZA201101669B (en) Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3 diol and paracetamol

Legal Events

Date Code Title Description
AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/18 20060101ALI20120306BHEP

Ipc: A61K 47/10 20060101ALI20120306BHEP

Ipc: A61K 47/02 20060101ALI20120306BHEP

Ipc: A61K 31/167 20060101ALI20120306BHEP

Ipc: A61K 31/135 20060101ALI20120306BHEP

Ipc: A61K 9/00 20060101AFI20120306BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121012